Sign In
Buy CPRX
$31.28
+0.0100 (+0.0320%)
At Close: Jun 03, 2026
What Makes Catalyst (CPRX) a Good Fit for 'Trend Investing'
09:50am, Monday, 21'st Oct 2024
If you are looking for stocks that are well positioned to maintain their recent uptrend, Catalyst (CPRX) could be a great choice. It is one of the several stocks that passed through our "Recent Price
Unlock Your Portfolio Value With These 4 High Earnings Yield Stocks
10:19am, Monday, 14'th Oct 2024
Add value to your portfolio with high earnings yield stocks like GOLD, CPRX, ALGT and AMX amid market uncertainty.
Catalyst Pharmaceuticals Donates $100,000 to the American Red Cross Hurricane Helene Relief Efforts
08:03am, Tuesday, 08'th Oct 2024
CORAL GABLES, Fla., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "the Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing,
New Strong Buy Stocks for October 8th
06:30am, Tuesday, 08'th Oct 2024
CPRX, HCI, DXC, CRAI and CRUS have been added to the Zacks Rank #1 (Strong Buy) List on October 8, 2024.
CPRX or STVN: Which Is the Better Value Stock Right Now?
12:41pm, Friday, 04'th Oct 2024
Investors interested in Medical - Drugs stocks are likely familiar with Catalyst Pharmaceutical (CPRX) and Stevanato Group (STVN). But which of these two stocks is more attractive to value investors?
Catalyst (CPRX) is on the Move, Here's Why the Trend Could be Sustainable
09:50am, Wednesday, 02'nd Oct 2024
If you are looking for stocks that are well positioned to maintain their recent uptrend, Catalyst (CPRX) could be a great choice. It is one of the several stocks that passed through our "Recent Price
Catalyst (CPRX) Upgraded to Buy: What Does It Mean for the Stock?
01:00pm, Tuesday, 01'st Oct 2024
Catalyst (CPRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024
08:03am, Tuesday, 01'st Oct 2024
CORAL GABLES, Fla., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, dev
Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Received Approval to Commercialize FIRDAPSE® in Japan
06:00am, Tuesday, 24'th Sep 2024
CORAL GABLES, Fla., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, d
Santhera Announces Half-Year 2024 Financial Results and Provides Corporate Update
01:00am, Thursday, 12'th Sep 2024
Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on September 12, 2024, at 14:30 CEST / 13:30 BST / 08:30 EDT.
Why Is Catalyst (CPRX) Up 8.3% Since Last Earnings Report?
12:38pm, Friday, 06'th Sep 2024
Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock?
Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
08:03am, Tuesday, 20'th Aug 2024
CORAL GABLES, Fla., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, dev
Wall Street Analysts See a 56.65% Upside in Catalyst (CPRX): Can the Stock Really Move This High?
10:56am, Thursday, 15'th Aug 2024
The average of price targets set by Wall Street analysts indicates a potential upside of 56.7% in Catalyst (CPRX). While the effectiveness of this highly sought-after metric is questionable, the posit
Recent Price Trend in Catalyst (CPRX) is Your Friend, Here's Why
09:51am, Thursday, 15'th Aug 2024
If you are looking for stocks that are well positioned to maintain their recent uptrend, Catalyst (CPRX) could be a great choice. It is one of the several stocks that passed through our "Recent Price
Top 3 Health Care Stocks That May Crash In August
08:35am, Wednesday, 14'th Aug 2024
As of Aug 14, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
